CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes General Counsel gave up 2,440 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 12,547 shares (to pay taxes)
- 4 Open-market buy Director bought 7,894,737 shares at $0.76 ($6,000,000)
- 4 Open-market buy Chief Financial Officer bought 15,000 shares at $0.59 ($8,850)
- 4 Open-market buy General Counsel bought 15,000 shares at $0.60 ($9,000)
- 4 Open-market buy Director bought 40,000 shares at $0.57 ($22,640)
- 4 Open-market buy President and CEO bought 40,000 shares at $0.60 ($24,000)
- 4 Open-market buy Chief Financial Officer bought 10,500 shares at $0.89 ($9,345)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 10,000 shares at $1.05 ($10,500)
Page 2 of 36 · 718 filings